FDA NDC Directory · JSON-LD · Markdown
NDC 0173-0887 · HUMAN PRESCRIPTION DRUG · POWDER
| Generic name | fluticasone furoate, umeclidinium bromide and vilanterol trifenatate |
|---|---|
| Labeler / Manufacturer | GlaxoSmithKline LLC |
| Marketing category | New Drug Application (innovator) · App NDA209482 |
| Dosage form / route | POWDER · RESPIRATORY (INHALATION) |
| Active ingredients | FLUTICASONE FUROATE (100 ug/1) UMECLIDINIUM BROMIDE (62.5 ug/1) VILANTEROL TRIFENATATE (25 ug/1) |
| Marketing started | 20170918 |
| Package count | 3 |
Source: openFDA. Public-domain (CC0).